Health CostsSee more about Health Costs
- state & global data
- view as grid
- view as list
The Peterson Center on Healthcare and the Kaiser Family Foundation have partnered to monitor how well the U.S. healthcare system is performing in terms of quality and cost. The Peterson-Kaiser Health System Tracker is an online hub providing comprehensive data on how the system is performing on critical quality and cost…
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses this week’s Centers for Medicare and Medicaid Services report on health spending and assesses the current effort to control health-care costs.
With the approval of new specialty drugs, such as the Hepatitis C treatments Sovaldi and Harvoni, states are mindful that the cost the Medicaid prescription drug benefit could increase. To achieve savings, and improve management and health outcomes, it is important to understand which drugs are most frequently prescribed and which drive spending. Using state drug utilization data provided through the Medicaid Drug Rebate Program, as well as an industry drug database, this issue brief examines trends in prescriptions and spending before rebates, and places findings in the context of policy discussion.
Majority Favors the Affordable Care Act’s Employer Mandate, But Opinion Can Shift When Presented With Pros and Cons
Recent news stories on the heath law did not attract most Americans’ attention, and many are unaware of details and implications of the developments Weeks before the Affordable Care Act’s employer mandate takes effect in January, a new Kaiser Family Foundation tracking poll finds that six in 10 Americans (60%)…
Medicare, the federal health program that provides health care and coverage to 54 million seniors and younger adults with permanent disabilities, is in the midst of an unprecedented slowdown in spending growth. A new issue brief from the Kaiser Family Foundation, How Much of the Medicare Spending Slowdown Can be…